Repligen Stock Price on November 29, 2024
| RGEN Stock | USD 150.54 0.55 0.37% |
Below is the normalized historical share price chart for Repligen extending back to April 29, 1986. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Repligen stands at 150.54, as last reported on the 1st of December, with the highest price reaching 150.79 and the lowest price hitting 148.49 during the day.
If you're considering investing in Repligen Stock, it is important to understand the factors that can impact its price. As of now, Repligen Stock is very steady. Repligen maintains Sharpe Ratio (i.e., Efficiency) of 0.0458, which implies the firm had a 0.0458% return per unit of risk over the last 3 months. We have found thirty technical indicators for Repligen, which you can use to evaluate the volatility of the company. Please check Repligen's Coefficient Of Variation of 3089.23, semi deviation of 3.32, and Risk Adjusted Performance of 0.0323 to confirm if the risk estimate we provide is consistent with the expected return of 0.14%.
At this time, Repligen's Total Stockholder Equity is very stable compared to the past year. As of the 1st of December 2024, Liabilities And Stockholders Equity is likely to grow to about 3 B, while Common Stock Shares Outstanding is likely to drop about 29.9 M. . At this time, Repligen's Price Earnings Ratio is very stable compared to the past year. As of the 1st of December 2024, Price To Operating Cash Flows Ratio is likely to grow to 92.34, while Price To Sales Ratio is likely to drop 10.04. Repligen Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 26th of March 1990 | 200 Day MA 154.5977 | 50 Day MA 140.845 | Beta 0.959 |
Repligen |
Sharpe Ratio = 0.0458
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | RGEN | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.08 actual daily | 27 73% of assets are more volatile |
Expected Return
| 0.14 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average Repligen is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Repligen by adding it to a well-diversified portfolio.
Price Book 4.1822 | Enterprise Value Ebitda 79.3007 | Price Sales 13.1803 | Shares Float 52.2 M | Wall Street Target Price 192.25 |
Related Headline
Intuitive Surgical Headline on 29th of November 2024
Northwest Ethical Investments L.P. Boosts Holdings in Intuit... by thelincolnianonline.com
Northwest Ethical Investments L.P. boosted its stake in Intuitive Surgical, Inc. by 50.6 percent during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 15,741 shares of the medical equipment providers stock after buying an additional 5,288 shares during
Repligen Valuation on November 29, 2024
It is possible to determine the worth of Repligen on a given historical date. On November 29, 2024 Repligen was worth 149.82 at the beginning of the trading date compared to the closed value of 150.54. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Repligen stock. Still, in general, we apply an absolute valuation method to find Repligen's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Repligen where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Repligen's related companies.
| Open | High | Low | Close | Volume | |
| 148.03 | 150.70 | 147.30 | 149.99 | 452,661 | |
11/29/2024 | 149.82 | 150.79 | 148.49 | 150.54 | 225,812 |
| 149.82 | 150.79 | 148.49 | 150.54 | 0.00 |
| Backtest Repligen | | | Repligen History | | | Repligen Valuation | Previous | Next |
Repligen Trading Date Momentum on November 29, 2024
| On December 01 2024 Repligen was traded for 150.54 at the closing time. The top price for the day was 150.79 and the lowest listed price was 148.49 . There was no trading activity during the period 0.0. Lack of trading volume on December 1, 2024 did not cause price change. The trading delta at closing time against the current closing price is 0.48% . |
Repligen Fundamentals Correlations and Trends
By evaluating Repligen's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Repligen's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Repligen financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Repligen Stock history
Repligen investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Repligen is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Repligen will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Repligen stock prices may prove useful in developing a viable investing in Repligen
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 56.4 M | 29.9 M | |
| Net Income Applicable To Common Shares | 213.9 M | 224.5 M |
Repligen Quarterly Net Working Capital |
|
Repligen Stock Technical Analysis
Repligen technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Repligen Period Price Range
Low | December 1, 2024
| High |
0.00 | 0.00 |
Repligen cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Repligen December 1, 2024 Market Strength
Market strength indicators help investors to evaluate how Repligen stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Repligen shares will generate the highest return on investment. By undertsting and applying Repligen stock market strength indicators, traders can identify Repligen entry and exit signals to maximize returns
Repligen Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Repligen's price direction in advance. Along with the technical and fundamental analysis of Repligen Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Repligen to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0323 | |||
| Jensen Alpha | (0.03) | |||
| Total Risk Alpha | (0.43) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.094 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Repligen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Repligen. If investors know Repligen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Repligen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.83) | Earnings Share (0.03) | Revenue Per Share 11.452 | Quarterly Revenue Growth 0.097 | Return On Assets 0.002 |
The market value of Repligen is measured differently than its book value, which is the value of Repligen that is recorded on the company's balance sheet. Investors also form their own opinion of Repligen's value that differs from its market value or its book value, called intrinsic value, which is Repligen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Repligen's market value can be influenced by many factors that don't directly affect Repligen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Repligen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Repligen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Repligen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.